Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Danaher
Pharma
Abcam's founder and former CEO Milner rejects Danaher buyout
One of Abcam's founders and major shareholders is pushing back against the proposed sale to Danaher.
Eric Sagonowsky
Sep 14, 2023 12:14pm
Danaher to buy antibody expert Abcam for $5.7B
Aug 28, 2023 9:18am
Catalent waylays its Q3 earnings report—again
May 15, 2023 10:05am
Danaher ditches Catalent buyout plan: Bloomberg
Apr 18, 2023 10:05am
Catalent draws buyout interest from Danaher: Bloomberg
Feb 6, 2023 11:24am
Cytiva acquires Michigan plant to produce pharmaceutical resins
Jul 18, 2022 9:26am
